Histopathological Patterns of Interstitial Lung Disease: A Multidisciplinary Approach to Distinguishing the Most Common Forms of Lung Fibrosis

Access Activity

Overview / Abstract:

Patients with interstitial lung disease (ILD) continue to suffer unacceptable delays in diagnosis and treatment initiation. Making an early and accurate diagnosis of ILD and its cause is key to initiating appropriate treatment and improving patient outcomes. This activity will use a case-based approach to address knowledge and practice gaps in ILD presentations and diagnoses, as well as to show the importance of a multidisciplinary care team for accurately diagnosing and monitoring ILD and providing and enhancing patient support.

Educational Objectives - At the conclusion of this activity, participants should be able to demonstrate the ability to:

- Recognize the clinical features of ILD and differentiate histological patterns of lung fibrosis common in IPF, CTD-ILD, and chronic HP, distinguishing IPF from other pulmonary conditions

- Recognize the importance and limitations of multidisciplinary discussion in the diagnosis of fibrotic interstitial lung diseases

Expiration

Jan 17, 2019

Discipline(s)

Nurse Practitioner , Physician CME, Physician Assistant CME

Format

Webinar / Webcast / Video

Credits / Hours

AACME - 1.00 AMA PRA Category 1 Credit

Accreditation

Provided by Potomac Center for Medical Education and Rockpointe

Presenters / Authors / Faculty

Brandon T. Larsen, MD, PhD
Senior Associate Consultant and Assistant Professor
Department of Laboratory Medicine and Pathology
Mayo Clinic Arizona
Scottsdale, AZ

Joseph Lasky, MD
Deming Internal Medicine Endowed Chair
Professor of Medicine
Section Chief of Pulmonary Disease
Critical Care and Environmental Medicine
Tulane University Health Sciences Center
New Orleans, LA

Activity Specialities / Related Topics

Pulmonary Medicine / COPD, Pathology, Cardiology / Cardiovascular

Sponsors / Supporters / Grant Providers

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Keywords / Search Terms

Rockpointe, interstitial lung disease, ILD, lung fibrosis, idiopathic pulmonary fibrosis, IPF, connective tissue disease, CTD, chronic hypersensitivity pneumonitis, CHP, pulmonology, pathology, PCME, Free CE, CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map